Finding that some patients with Hodgkins Disease and CFS improved their CFS symptoms after Rituximab
immunomodulation by B cell depletion biomedcentral.com/1471-2377... further trials were carried out with larger numbers.
The results of this trial in 2011 ncbi.nlm.nih.gov/pmc/articl... had two positive outcomes, first it improved symptoms for 67% of those involved in the phase two trial, the second positive outcome was an apology from Norways Directorate of Health
euro-me.org/news-Q42011-003...
Bjørn Guldvog, Deputy Director General of theNorwegian Directorate of Health made the following statement;
"I think that we have not cared for people with ME to a great enough extent. I think it is correct to say that we have not established proper health care services for these people, and I regret that."
The best may yet be ahead of us as stage three trials are underway simmaronresearch.com/2015/0... with the biggest trial that is actually four trials in one.